About aroluxe-admin

This author has not yet filled in any details.
So far aroluxe-admin has created 2 blog entries.

FDA Clears the Morph Device and Grants Indication for Use as an Aid for Opioid Withdrawal

By |2018-08-28T17:17:42+00:00August 28th, 2018|

Therapeutic Neuromodulation Systems Announces: FDA Clears the Morph Device and Grants Indication for Use as an Aid for Opioid Withdrawal On May 2nd, 2018, the US Food and Drug Administration (FDA) granted a 510(k) clearance for the Morph Device, with an indication for use as an aid in the treatment of opioid withdrawal. The announcement was [...]

FDA Indication

By |2018-08-28T17:12:07+00:00May 2nd, 2018|

Therapeutic Neuromodulation Systems, LLC, a U.S. based sales and marketing organization for the Morph Device, announces the US Food and Drug Administration (FDA) has approved its wearable device for the treatment of opioid withdrawal symptoms. The Morph Device is a percutaneous nerve stimulator for substance use disorders.